Drug Profile
Seproxetine
Alternative Names: LY 215229; NorfluoxetineLatest Information Update: 10 Sep 1998
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Propylamines
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 10 Sep 1998 No-Development-Reported for Depression (PO)
- 09 Jan 1997 Preclinical development for Depression (PO)
- 20 Feb 1996 New profile